REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US76152G2093
REVIVA PHARMACEUTICALS HOLDINGS, INC. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -20.20 m USD |
| EBIT | -20.14 m USD |
| Net income | -19.86 m USD |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, such as schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer's disease, and Parkinson's disease psychosis. It also engages in the clinical development for respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis. In addition, the company is in preclinical development for the treatment of psoriasis; and RP1208 for the treatment of depression and obesity. The company was founded in 2018 and is headquartered in Cupertino, California.
More stocks
- I-ON Digital Corp. (IONI)
- Scienture Holdings, Inc. (SCNX)
- AMARIN CORP PLC\UK (AMRN)
- Pulmatrix, Inc. (PULM)
- Cadrenal Therapeutics, Inc. (CVKD)
- Aqua Metals, Inc. (AQMS)
- AleeanPeace Group Holdings Ltd (APGH)
- Luvu Brands, Inc. (LUVU)
- Versus Systems Inc. (VS)
- Limitless X Holdings Inc. (LIMX)
- Oncotelic Therapeutics, Inc. (OTLC)
- Modular Medical, Inc. (MODD)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.